An authoritative report by the President’s Cancer Panel, validates the concerns of independent critics who have warned about the serious health hazards posed by toxic chemicals which are blamed for the alarming rates of cancer.
"Did you have permission to use Havasupai blood for your research?" At the heart of this case is a conflict of interests between scientists at powerful institutions that stand to profit from DNA research and powerless members of an underclass.
Dr. Charles Schulz is scheduled to present "How to help parents of a first psychotic episode patient," at Annual APA Meeting –it is closed to public. What is it that psychiatrists and the APA do not want parents or the public to know?
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack."
Why Has Columbia Expended So Much Effort to Avoid the Conclusion of Patient Harm?
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
"Anything you put in that book, any little change you make, has huge implications not only for psychiatry but for pharmaceutical marketing, research, for the legal system, for who’s considered to be normal or not, for who’s considered disabled," said Dr. Michael First, professor of psychiatry at Columbia University who edited the DSM4l but is not involved in the DSM5.
In December, 2009, Bloomberg News published an investigative report by David Evans reported, "Big Pharma’s Crime Spree" documenting major court settlements: "Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. Six of the companies…
TRUTHOUT reports: US Air Force Adds Kids to Pentagon’s MANDATORY H1N1 Vaccine Program
In the first half of the twenty-first century, U.S. psychiatrists are prescribing the second generation neuroleptics—Zyprexa, Risperdal, Geodon, Seroquel, Abilfy—to coerce innocent children and the elderly into submission.
"The reported rate of serious adverse events is greater than the incidence rate of cervical cancer."
Dr. Joshua Sharfstein, the FDA’s principal deputy commissioner, acknowledged: “The message here is that there were problems with the integrity of F.D.A.’s decision-making process that have solutions.”
